Xeris Pharmaceuticals | XERS - Stock


Xeris Pharmaceuticals reported $74.23M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Celltrion KRW 122.94B 2.59T Dec/2025
Cspc Pharmaceutical CNY 2.87B 259.23M Jun/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Eli Lilly USD 14.53B 785M Mar/2026
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Medical Developments International AUD 9.45M 679K Jun/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Organigram Holdings CAD 132.71M 8.76M Dec/2025
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.12B 27.6M Mar/2026
Pharma Mar EUR 53.12M 2.48M Mar/2026
Qiagen NV USD 301.89M 11.66M Dec/2025
Sartorius EUR 827.1M 34.9M Mar/2026
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
Tilray USD 282.79M 11.9M Jun/2025
Zealand Pharma A/S 10.7M 9.9M Dec/2024
Zz Pientze Pharmaceu CNY 6.28B 553.86M Mar/2026